Log in to save to my catalogue

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer:...

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer:...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1c2b486e0e1f4300a4ecaaa697d58abe

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes

About this item

Full title

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes

Publisher

London: BioMed Central Ltd

Journal title

BMC cancer, 2022-11, Vol.22 (1), p.1-1148, Article 1148

Language

English

Formats

Publication information

Publisher

London: BioMed Central Ltd

More information

Scope and Contents

Contents

Background KRAS-mutated non-small cell lung cancer (NSCLC) accounts for 23-35% and 13-20% of all NSCLCs in white patients and East Asians, respectively, and is therefore regarded as a major therapeutic target. However, its epidemiology and clinical characteristics have not been fully elucidated because of its wide variety of mutational subtypes. He...

Alternative Titles

Full title

Differential properties of KRAS transversion and transition mutations in non-small cell lung cancer: associations with environmental factors and clinical outcomes

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_1c2b486e0e1f4300a4ecaaa697d58abe

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_1c2b486e0e1f4300a4ecaaa697d58abe

Other Identifiers

ISSN

1471-2407

E-ISSN

1471-2407

DOI

10.1186/s12885-022-10246-7

How to access this item